Difficulty: Medium
Average Score: 79%
Practice
A client has ordered a thrombolytic medication for the treatment of CVA. Which type of stroke should not be treated with a thrombolytic?
Correct answer
A
Rationale
### **Comprehensive Rationale for the Correct Answer (A: Hemorrhagic Stroke)**
**1. Correct Answer (A): Hemorrhagic Stroke**
Thrombolytic medications (e.g., alteplase, tenecteplase) work by breaking down blood clots, which is beneficial in **ischemic strokes** (caused by blocked arteries). However, in a **hemorrhagic stroke**, bleeding occurs in or around the brain due to a ruptured blood vessel. Administering a thrombolytic in this scenario would **worsen bleeding** by inhibiting clotting mechanisms, leading to increased intracranial hemorrhage, higher morbidity, and potentially fatal outcomes. Thus, thrombolytics are **contraindicated** in hemorrhagic strokes, making **A the correct answer**.
**2. Incorrect Answer (B): Thrombotic Stroke**
A thrombotic stroke is a subtype of **ischemic stroke** caused by a clot obstructing blood flow in the brain. Thrombolytics are **first-line treatments** for ischemic strokes (if administered within the 3-4.5-hour window), as they dissolve clots and restore perfusion. Since this option incorrectly suggests that thrombotic strokes should **not** be treated with thrombolytics, it is **wrong**.
**3. Incorrect Answer (C): Both Types Can Be Treated with a Thrombolytic**
This choice falsely claims that thrombolytics are safe for **both** hemorrhagic and thrombotic strokes. While they are appropriate for **ischemic** (thrombotic/embolic) strokes, they **must never** be given in hemorrhagic strokes due to the risk of exacerbating bleeding. Thus, this option is **incorrect**.
**4. Incorrect Answer (D): Neither Type Can Be Treated with a Thrombolytic**
This option incorrectly asserts that **no strokes** should be treated with thrombolytics. While they are **contraindicated** in hemorrhagic strokes, they are **critical** in ischemic strokes when given promptly. Therefore, this choice is **false**.
### **Key Clinical Considerations:**
- **Ischemic strokes (thrombotic/embolic)**: Thrombolytics are **lifesaving** if administered early (ideally within 3 hours, up to 4.5 hours in select cases).
- **Hemorrhagic strokes**: Thrombolytics are **dangerous** and increase mortalityÔÇömanagement focuses on controlling bleeding (e.g., BP control, surgical intervention).
- **Imaging confirmation (CT/MRI)** is **essential** before thrombolytic administration to rule out hemorrhage.
### **Conclusion:**
The **only correct answer is A (Hemorrhagic stroke)** because thrombolytics are **absolutely contraindicated** in bleeding strokes. The other options either misrepresent the use of thrombolytics in ischemic strokes (B, D) or incorrectly include hemorrhagic strokes as candidates (C). Proper stroke subtype diagnosis is **critical** before initiating therapy.
**1. Correct Answer (A): Hemorrhagic Stroke**
Thrombolytic medications (e.g., alteplase, tenecteplase) work by breaking down blood clots, which is beneficial in **ischemic strokes** (caused by blocked arteries). However, in a **hemorrhagic stroke**, bleeding occurs in or around the brain due to a ruptured blood vessel. Administering a thrombolytic in this scenario would **worsen bleeding** by inhibiting clotting mechanisms, leading to increased intracranial hemorrhage, higher morbidity, and potentially fatal outcomes. Thus, thrombolytics are **contraindicated** in hemorrhagic strokes, making **A the correct answer**.
**2. Incorrect Answer (B): Thrombotic Stroke**
A thrombotic stroke is a subtype of **ischemic stroke** caused by a clot obstructing blood flow in the brain. Thrombolytics are **first-line treatments** for ischemic strokes (if administered within the 3-4.5-hour window), as they dissolve clots and restore perfusion. Since this option incorrectly suggests that thrombotic strokes should **not** be treated with thrombolytics, it is **wrong**.
**3. Incorrect Answer (C): Both Types Can Be Treated with a Thrombolytic**
This choice falsely claims that thrombolytics are safe for **both** hemorrhagic and thrombotic strokes. While they are appropriate for **ischemic** (thrombotic/embolic) strokes, they **must never** be given in hemorrhagic strokes due to the risk of exacerbating bleeding. Thus, this option is **incorrect**.
**4. Incorrect Answer (D): Neither Type Can Be Treated with a Thrombolytic**
This option incorrectly asserts that **no strokes** should be treated with thrombolytics. While they are **contraindicated** in hemorrhagic strokes, they are **critical** in ischemic strokes when given promptly. Therefore, this choice is **false**.
### **Key Clinical Considerations:**
- **Ischemic strokes (thrombotic/embolic)**: Thrombolytics are **lifesaving** if administered early (ideally within 3 hours, up to 4.5 hours in select cases).
- **Hemorrhagic strokes**: Thrombolytics are **dangerous** and increase mortalityÔÇömanagement focuses on controlling bleeding (e.g., BP control, surgical intervention).
- **Imaging confirmation (CT/MRI)** is **essential** before thrombolytic administration to rule out hemorrhage.
### **Conclusion:**
The **only correct answer is A (Hemorrhagic stroke)** because thrombolytics are **absolutely contraindicated** in bleeding strokes. The other options either misrepresent the use of thrombolytics in ischemic strokes (B, D) or incorrectly include hemorrhagic strokes as candidates (C). Proper stroke subtype diagnosis is **critical** before initiating therapy.